InterCure Balance Sheet Health
Financial Health criteria checks 3/6
InterCure has a total shareholder equity of ₪462.1M and total debt of ₪133.1M, which brings its debt-to-equity ratio to 28.8%. Its total assets and total liabilities are ₪740.9M and ₪278.8M respectively.
Key information
28.8%
Debt to equity ratio
₪133.07m
Debt
| Interest coverage ratio | n/a |
| Cash | ₪20.30m |
| Equity | ₪462.12m |
| Total liabilities | ₪278.77m |
| Total assets | ₪740.89m |
Recent financial health updates
Recent updates
InterCure: A Cannabis Industry Leader Still Flying Under The Radar
Jun 30InterCure: Bargain Israel Cannabis Play
Apr 22InterCure: A Leader In Global Cannabis
Sep 06InterCure reports Q2 results
Aug 15InterCure Is Growing In The Massive Global Cannabis Market
Jun 07IntureCure: Israel Recreation Cannabis Boom On The Way
Feb 16InterCure Chairman Ehud Barak, CEO Alex Rabinovitch - Israel Cannabis And Beyond (Video)
Nov 08InterCure: Internationally Profitable Cannabis (Podcast Transcript)
Sep 19InterCure: Ignored Uplisting
Sep 09Financial Position Analysis
Short Term Liabilities: INCR's short term assets (₪370.8M) exceed its short term liabilities (₪208.9M).
Long Term Liabilities: INCR's short term assets (₪370.8M) exceed its long term liabilities (₪69.9M).
Debt to Equity History and Analysis
Debt Level: INCR's net debt to equity ratio (24.4%) is considered satisfactory.
Reducing Debt: INCR's debt to equity ratio has increased from 5% to 28.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if INCR has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if INCR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.